Research interests & activities
2011: International Mobility Fund grant.
2010: FRST Bridge to Employment Fellowship.
2008: Finalist in MacDiarmid Young Scientist of the Year Awards.
2008: NZSAP Animal Science Award.
2007-09: FRST Postdoctoral Fellowship.
2007: NZIAHS Postgraduate Award.
2006: Best Young Investigator Poster Presentation at the International Conference on Nutrigenomics and Gut Health, Auckland.
2003: Best Postgraduate Student Poster Prize at the NZ Institute of Chemistry Conference, Nelson.
2002: C. Alma Baker Trust Fellowship.
2002: Leonard Condell Doctoral Scholarship.
2001-04: Meat NZ Doctoral Scholarship.
Anderson RC, Ulluwishewa D, Young W, Ryan L, Henderson G, Meijerink M, Maier E, Wells JM & Roy NC (2016) Human oral isolate Lactobacillus fermentum AGR1487 induces a pro-inflammatory response in germ-free rat colons. Scientific Reports, 6:Article 20318.
Dalziel J, Mohan V, Peters J, Anderson RC, Gopal, PK & Roy NC (2015). The probiotic Escherichia coli Nissle 1917 inhibits propagating colonic contractions in the rat isolated large intestine. Food & Function 6(1):256-263.
Maier E, Anderson RC & Roy NC (2015). Understanding how commensal obligate anaerobic bacteria regulate immune functions in the large intestine. Nutrients 7(1):45-73.
Sengupta R, Anderson RC, Altermann E, McNabb WC, Ganesh S, Armstrong KM, Moughan PJ & Roy NC (2015). Lactobacillus fermentum AGR1487 cell surface structures and supernatant increase paracellular permeability through different pathways. MicrobiologyOpen, 4(4), 541â€“552.
Ulluwishewa D, Anderson RC, Young W, McNabb WC, van Baarlen P, Moughan PJ, Wells JM & Roy NC (2015). Live Faecalibacterium prausnitzii in an apical anaerobic model of the intestinal epithelial barrier. Cellular Microbiology 17(2):226-240.
Anderson RC, Young W, Clerens S, Cookson AL, McCann MJ, Armstrong KM & Roy NC (2013). Human oral isolate Lactobacillus fermentum AGR1487 reduces intestinal barrier integrity by increasing the turnover of microtubules in Caco-2 cells. PLoS ONE 8(11):e78774.
Russ AE, Peters JS, McNabb WC, Barnett MPG, Anderson RC, Park Z, Zhu S, Maclean P, Young W, Reynolds GW & Roy NC (2013). Gene expression changes in the colon epithelium are similar to those of intact colon during late inflammation in interleukin-10 gene deficient mice. PLoS ONE 8(5):e63251.
Sengupta R, Altermann E, Anderson RC, McNabb WC, Moughan PJ & Roy NC (2013). The role of cell surface architecture of lactobacilli in host-microbe interactions in the gastrointestinal tract. Mediators of Inflammation 237921.
Meijerink M, Ulluwishewa D, Anderson RC & Wells JM (2011). Cryopreservation of monocytes or differentiated immature DCs leads to an altered cytokine response to TLR agonists and microbial stimulation. Journal of Immunological Methods 373:136-142.
Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM & Roy NC (2011). Regulation of tight junction permeability by intestinal bacteria and dietary compounds. Journal of Nutrition 141:769-776.
Anderson RC, Bermingham EN, McNabb WC, Cookson AL, Tavendale M, Armstrong KM, Knowles S & Roy NC (2010). Moderate levels of dietary sheep milk powder reduce experimentally-induced colonic inflammation in rats. Animal Production Science 50:714-721.
Anderson RC, Cookson AL, McNabb WC, Park Z, McCann M & Roy NC (2010). Lactobacillus plantarum MB452 increases the integrity of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiology 10:Article 316.
Anderson RC, Cookson AL, Kelly WJ, McNabb WC & Roy NC (2010). Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function. FEMS Microbiology Letters 309:184-92.
Russ A, Barnett MPG, McNabb WC, Anderson RC, Reynolds GW & Roy NC (2010). Post-weaning effects of milk and milk components on the intestinal mucosa in inflammation. Mutation Research 690:64-70.
Anderson RC & Yu PL (2008). Pilot-scale extraction and antimicrobial activity of crude extract from ovine neutrophils. Process Biochemistry 43:882-886.
Anderson RC & Yu PL (2008). Fragments of proregion of cathelicidins and other immune related peptides display antimicrobial activity. Biotechnology Letters 30:813-818.
Anderson RC & Yu PL (2005). Factors affecting the antimicrobial activity of ovine-derived cathelicidins against E. coli 0157:H7. International Journal of Antimicrobial Agents 25:205-210.
Treffers C, Chen L, Anderson RC & Yu PL (2005). Isolation and characterisation of antimicrobial peptides from deer neutrophils. International Journal of Antimicrobial Agents 26:165-169.
Anderson RC, Hancock REW & Yu PL (2004). Antimicrobial activity and bacterial membrane interaction of ovine-derived cathelicidins. Antimicrobial Agents and Chemotherapy 48:673-676.
Anderson RC, Haverkamp R & Yu PL (2004). Investigation of morphological changes to S. aureus induced by ovine-derived antimicrobial peptides using TEM and AFM. FEMS Microbiology Letters 240:105-110.
Anderson RC, Wilkinson B & Yu PL (2004). Ovine antimicrobial peptides: new products from an age-old industry. Australian Journal of Agricultural Research 55:69-75.
Anderson RC & Yu PL (2003). Isolation and characterization of proline/arginine-rich cathelicidin peptides from ovine neutrophils. Biochemical and Biophysical Research Communications, 312:1139-1146.